Archive | medicine & science RSS feed for this section

Cancer Research Saves Lives

18 Apr

The AACR debuted at its annual conference today an informative video about the accomplishments and possibilities of cancer research. Check it out.

Susan Desmond-Hellmann Featured in the San Francisco Chronicle

11 Apr

UCSF’s Dr. Susan Desmond-Hellmann is profiled in the Sunday, April 11, 2010 issue of the San Francisco Chronicle. The story is featured on the front page.

A Year of Drug Development Firsts?

30 Dec

CNBC’s Mike Huckman looks back at pharma’s biggest decade, and also looks ahead at    what’s to come in today’s segment “Big Pharma’s Big Decade.” UCSF’s Chancellor Dr. Susan  Desmond-Hellmann is featured in the program. Dr. Desmond-Hellmann who brought the world’s anti-cancer blockbuster drugs to market says what she’s “most proud of is that we changed the way people think about cancer.”

2010 could be a year of firsts– the first therapeutic vaccine for prostate cancer, first Lupus    drug, first once a week drug to treat diabetes, and  the first new flu vaccine technology since the 1950’s.

According to Dr. Desmond-Hellmann, “what is tremendous is how there is literally an explosion of biology – it should be a golden era.” She also believes that there could be a significant break-through in Alzheimer’s disease on the horizon. Drugs today just treat the symptoms but don’t slow the progression.

Dr. Desmond-Hellmann concludes by saying: “If there was a genuine breakthrough in Alzheimer’s we’re talking about the kinds of medicines that could be the biggest products in the world… bigger than Lipitor and Avastin… from a business perspective this could be huge.”

Watch the video here.

Susan Desmond-Hellmann: FORBES Most Powerful Innovator

13 Nov


UCSF’s Chancellor, Susan Desmond-Hellmann, MD, MPH,  was selected by FORBES as one of its 7 Most Powerful Innovators of 2009. You can read the story here. According to the article, Desmond-Hellmann’s  most influential innovations were  the blockbuster cancer drugs Avastin and Herceptin.

Susan Desmond-Hellmann, a physician and cancer researcher, is a hero to legions of cancer patients. While president of product development at Genentech from 2004 to April 2009, she played an integral role in the selection, testing and development of Avastin, a colon cancer drug with annual sales of $9 billion, and Herceptin, a breast cancer drug with sales of $7.8 billion. In August 2009 she became the chancellor of UCSF, a powerhouse in medical research, where she aims to continue fostering innovation in health care and science.

Why Global Health Matters to California

13 Nov

Innovation and Healthcare Reform

13 Nov

UCSF’s Elizabeth Blackburn Wins Nobel Prize in Medicine

5 Oct

UCSF’s Elizabeth Blackburn joins an elite group of women scientists that has received the Nobel Prize in Medicine. Her award brings the number of female recipients to 10, out of a total of 195 scientists who have received the award since it was established in 1901. Watch the video of today’s Nobel press conference: